Beyond AirXAIR -4.80%27 Days Payable is 116.24 as of Mar. 2026, which is 45% below its 10-year median of 212.94. GuruFocus rates XAIR with a GF Score™ of 27/100 and a GF Value™ of $9.75 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Beyond Air ranks better than 66.42% on this metric.
Beyond Air's average Accounts Payable for the
three
months ended in Mar. 2026 was $2.31 Mil. Beyond Air's Cost of Goods Sold for the
three
months ended in Mar. 2026 was $1.81 Mil.
Hence, Beyond Air's Days Payable for the
three
months ended in Mar. 2026 was 116.24.
The historical rank and industry rank for Beyond Air's Days Payable or its related term are showing as below:
XAIR'
s Days Payable Range Over the Past 10 Years
Min: 95.6 Med: 212.94 Max: 1034.17
Current: 95.6
During the past 12 years, Beyond Air's highest Days Payable was 1034.17. The lowest was 95.60. And the median was 212.94.
XAIR's Days Payable is ranked better than 66.42% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 68.07
vs XAIR: 95.60
Beyond Air's Days Payable
declined
from Mar. 2025 (165.97) to Mar. 2026 (116.24).
It may suggest that Beyond Airaccelerated paying its suppliers.
Beyond Air Days Payable Related Terms
Beyond Air Days Payable Historical Data
* Premium members only.
The historical data trend for Beyond Air's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Beyond Air's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beyond Air Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Beyond Air's Days Payable distribution charts can be found below:
* The bar in red indicates where Beyond Air's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Beyond Air's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beyond Air (XAIR) has a Days Payable of 116.24 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Beyond Air and its competitors. This is 45% below median its historical median of 212.94. Over the past decade, Beyond Air's Days Payable has ranged from 95.60 to 1,034.17. According to the industry distribution chart, Beyond Air ranks #267 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 33.6%.
Is Beyond Air's Days Payable too high?
Beyond Air's current Days Payable of 116.24 is 45% below median its 10-year median of 212.94. Over the past 10 years, this metric has ranged from a low of 95.60 to a high of 1,034.17. The Medical Devices & Instruments industry median Days Payable is 68.07. Beyond Air's value of 116.24 is 70.8% above this industry median. Based on the distribution chart, Beyond Air ranks #267 out of 795 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Beyond Air has a GF Score™ of 27/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Beyond Air's Days Payable compare to VVOS and TNON?
According to the Medical Devices & Instruments industry distribution chart, Beyond Air ranks #267 out of 795 companies for Days Payable. This puts Beyond Air in the upper half of its industry. The industry median Days Payable is 68.07. Beyond Air's value of 116.24 is 70.8% above this benchmark. Historically, Beyond Air's own Days Payable has ranged from 95.60 to 1,034.17 over the past decade. While the company's 10-year median is 212.94 vs. the industry median of 68.07, Beyond Air has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.07, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Beyond Air's current Days Payable of 116.24 is 70.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Beyond Air and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beyond Air's current Days Payable is 116.24, which is 45% below median its own 10-year median of 212.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beyond Air stock overvalued right now?
Based on GuruFocus' analysis, Beyond Air (XAIR) is currently considered Possible Value Trap. The stock's GF Value™ is $9.75, compared to a current price of $0.46 — trading 95.2% below its estimated fair value. The current Days Payable is 116.24, which is 45% below median its 10-year median of 212.94 and 70.8% above the Medical Devices & Instruments industry median of 68.07. Beyond Air's overall GF Score™ is 27/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Beyond Air (XAIR), the current Days Payable is 116.24 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Beyond Air (XAIR) Overvalued in 2026?
Based on GuruFocus' analysis, Beyond Air stock appears to be undervalued.
The current stock price of $0.46 is trading 95.2% below its estimated GF Value™ of $9.75.
GuruFocus considers Beyond Air to be Possible Value Trap.
Key valuation signals for XAIR:
Days Payable: 116.24 (45% below median its 10-year median of 212.94)
GF Value™: $9.75 vs. price of $0.46 (95.2% below fair value)
Industry Position: 70.8% above the Medical Devices & Instruments median (#267 of 795)
No single metric tells the full story. See the XAIR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.
27GF Score
Get the complete analysis for XAIR
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XAIR has been successfully added to your 
